Workshops in Serbian high schools

Ana Damjanović, Aleksandra Stanojević and Ana Đurić held inspiring workshops in two high schools, Miloje Vasić in Veliko Gradište and Mladost in Petrovac na Mlavi on May 13, 2024. During the workshops, STEPUPIORS researchers discussed with the 2nd and 3rd grade pupils and their teachers about healthy lifestyles and the challenges scientists and clinicians face in the battle against cancer. The STEPUPIORS team emphasized the importance of the engagement of new young generations of researchers in Serbia in this important fight.




STEPUPIORS visit to CeGaT

Dr Ana Đurić Ex Mariokov and Dr Milena Cavic performed a stakeholder visit to the R&I Company CeGaT GmbH in Tubingen, Germany on May 17, 2024, alongside selected clinicians and researchers from Serbia. CeGaT staff presented their facilities and the wide range of their activities in the field of genetic diagnostics, genetic counseling and diseases diagnostics. Possibilities for collaboration in the field of translational oncology regarding sequencing services, liquid biopsy, immune cell profiling and different research and pharma solutions were also outlined.
The visit opened up new opportunities for joint project applications between the IORS and successful R&I companies with a great impact on the benefit of Serbian cancer patients.




May 2024 Project Activities

May 2024 was a successful congress month for the participants of the STEPUPIORS project.

Dr Suzana Stojanovic-Rundic and Dr Mladen Marinkovic attended the ESTRO 2024 Congress organized by the European Society for Radiotherapy and Oncology titled: Radiation Oncology: Bridging the Care Gap, Glasgow, UK.

Dr Radmila Jankovic and Dr Jelena Spasic gave lectures at the CUMO2024 Congress organized by the Montenegro Society for Medical Oncology in Budva, Montenegro.

Dr Mladen Marinkovic gave a lecture at the 2nd National Oncology Congress held in Nis, Serbia.

Dr Teresa Botta-Orfila presented a collaborative abstract: “International Collaborative Biobanking: Shaping the future together” at the Europe Biobank Week Congress 2024 held in Vienna, Austria.

Dr Marija Đorđić Crnogorac presented a project abstract and Dr Ana Krivokuca presented a lecture at the 15th International Symposium on Variants in the Genome, held in Porto, Portugal


Lecture at TRANSLACORE COST Action meeting

Aleksandra Stanojevic, MSc, participated in the annual Management Committee Meeting of the COST action CA21154 – Translational control in Cancer European Network – TRANSLACORE held in Prague, Czech Republic at Milan Hašek Conference Hall.

During the first day of meeting participants delivered presentations about translational control in cancer research. The second day of the meeting was dedicated to Working Group meeting and Management Committee Meeting. Aleksandra gave a 15min presentation “Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy”.

The meeting aimed at integrating disciplines and knowledge across Europe to promote translational control in cancer, produced exciting debates and new collaborations. Following the meeting, a number of prospects for collaboration with other participants in this Action appeared, including scheduled meetings to discuss grant and project an opportunity in the future.




STEPUPIORS supported Webinar

During the Scientific Day 2024 of the Serbian Association for Cancer Research Prof. Antoni Castells from Hospital Clínic de Barcelona delivered a STEPUPIORS supported Webinar:  “Colorectal cancer screening: great opportunities and new challenges”
The meeting was attended by Serbian and international researchers from various institutions, leading to vivid discussions on this globally important topic with insight from different countries.




Open Day on colorectal cancer

On March 25, the IORS hosted an Open Day focused on colorectal cancer. The event aimed to raise awareness, support affected individuals, and emphasize the importance of prevention and early detection. It featured oncology experts, medical professionals, representatives from patient associations, and a genetic counselling team. Attendees heard a patient’s experience with treatment and genetic testing for hereditary syndromes, while discussions covered prevention, symptoms, diagnosis, treatment, and rehabilitation of colorectal cancer.




STEPUPIORS lectures at TRANSLACORE COST Action webinar

The 6th Webinar “Cancer medicine – Rectal Cancer Predictive Biomarkers” organized by the Early Career Investigators network under the TRANSLACORE COST Action was held on Monday, April 22nd and featured STEPUPIORS lecturers Milena Cavic, Mladen Marinkovic and Aleksandra Stanojevic.

Τhe webinar focused on the following lectures:

“Rectal Cancer Predictive Biomarkers – STEPUPIORS Horizon Europe Project” by Milena Cavic, IORS

“Pretreatment MRI Radiomics in Rectal Cancer Chemoradiotherapy Prediction” by Mladen Marinkovic, IORS

“In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer” by Aleksandra Stanojevic, IORS

The meeting was moderated by Dr Paulina Podszywalow-Bartnicka from the

Nencki Institute of Experimental Biology, Warsaw, Poland. Exciting discussions were held and new collaborations formed from this new network dedicated to bridging disciplines and expertise across Europe in order to advance translational control in cancer.



Midterm Review Meeting

On March 18, 2024, the STEPUPIORS consortium had a Midterm Review Meeting with the Project Officer Dr Irimie Doru-Leonard of the Research Executive Agency, European Commission, and an External Monitor Prof. Roman Volchenkov, from the University of Oslo, Norway. Main project results, deliverables, milestones and future plans were outlined by work package leaders and project managers from all partner institutions, in a friendly and stimulating atmosphere. The midterm report was approved by the REA EuC and the consortium participants look forward to next project steps.

 

STEPUPIORS midterm review participants:

Dr Ana Krivokuca, IORS, WP1 co-leader1
Dr Miljana Tanic, IORS, WP1 co-leader2
Dr Radmila Jankovic, IORS, WP2 leader
Prof. Ieronymos Zoidakis, BRFAA, WP3 leader
Dr Sergi Castellví-Bel, FRCB-IDIBAPS, WP4 leader
Dr Milena Cavic, IORS, WP5 leader/Project Coordinator
Dr Remond Fijneman, NKI-AVL PI
Dr Ana Djuric, IORS Project manager
Dr Meike de Wit, NKI-AVL Project manager
Dr Christos Ilioudis, BRFAA Project manager
Dr Joan Pallares, FRCB-IDIBAPS Project manager



STEPUPIORS at AACR2024 Congress

STEPUPIORS PIs Milena Cavic and Remond Fijneman presented latest project results and advancements in the colorectal cancer and liquid biopsy field at the science-packed AACR24 Congress of the American Association for Cancer Research, held from Apr 05-10, 2024 in San Diego, USA. Exciting discussions and plans for future projects on colorectal cancer predictive biomarkers were made with various stakeholders.
Cavic M, Djuric A, Marinkovic M, Stanojevic A, Tanic M, Bjelogrlic S, Spasic J, Damjanovic A,  Djordjic Crnogorac M, Vuletic A, Mirjacic Martinovic K, Radulovic M, Stojanovic-Rundic S, Krivokuca A, Jankovic R, Castellvi-Bel S, Zoidakis J, Fijneman R. Employing widening funds to address inequity in cancer research – example of the STEPUPIORS collaborative rectal cancer project [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1304.https://doi.org/10.1158/1538-7445.AM2024-1304.

https://aacrjournals.org/cancerres/article/84/6_Supplement/1304/738874/Abstract-1304-Employing-widening-funds-to-address